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 B Chapter 13 
A Evaluating the ethics of health promotion: understanding 
informed participation 
B Dalya Marks 
Ethical issues in health promotion are often overlooked. Interventions are planned, 
executed and evaluated with little regard to ethical concerns. There is an assumption 
that health promotion is good for you and compliance is expected.  This chapter 
examines some of the issues surrounding participation in health promotion 
interventions and considers what is required to acquire informed consent and 
promote informed decision-making.  
Informed consent requires that participants are provided with unbiased information 
on the risks and benefits of an intervention, and are free decide whether or not to 
take part. In addition to practical problems in delivering the information, acquiring 
informed consent might create conflict between health professionals’ desire to 
achieve a high programme uptake whilst accepting that an informed person might 
decide not to participate. This chapter will suggest that in evaluating a health 
promotion programme, outcomes should not be measured simply in terms of uptake, 
but informed uptake.  Evaluation should include measures of knowledge and 
empowerment, not simply acceptance or refusal.  
B Current Guidelines 
The UK General Medical Council (GMC) guidelines for seeking patients’ consent 
(see Box 1) do not state how much information should be given nor how it should be 
conveyed to facilitate informed decision-making.  
 
 
 
 
 
 
 
 
BBox 1 Guidelines on informed consent for screening procedures 
The following should be explained before the test: 
 The purpose of screening  
 The likelihood of receiving a positive or negative results 
 The chance of a false positive or false negative result 
 The risks and uncertainties of the process 
 The potential for financial and/or social discrimination 
The following should be explained after the test: 
 Follow up plans 
 Availability of support or counselling services 
(General Medical Council 1999). 
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 The UK National Screening Committee guidelines (Department of Health 2000) 
state:  
There is a responsibility to ensure that those who accept an invitation (to 
screening) do so on the basis of informed choice, and appreciate that in 
accepting an invitation or participating in a programme to reduce their risk of 
a disease there is a risk of an adverse outcome                 
.  
Informed choice implies that a decision to refuse a test or an invitation to participate 
is as valid an outcome as attendance.  
B Participant involvement in decision-making 
An individual should be able to make an informed choice about whether to 
participate or not, through provision of the necessary information about the benefits 
and disadvantages of such a decision (Department of Health 2000; Jepson et al. 
2000). This process has been described as  
a reasoned choice….made by a reasonable individual using relevant 
information about the advantages and disadvantages of all the possible 
courses of action, in accord with the individual’s beliefs                                                     
(Bekker et al. 1999).  
Whether this adequately describes what is experienced is unclear. Although it 
corresponds well with respect for autonomy, little is known about the effectiveness 
of involving patients in decisions about their care, or the effect that sharing 
information will have (Entwistle et al. 1998).  
Informed choice requires a discussion to take place between a participant and the 
health professional promoting the ‘informed’ aspect. There is a continuum of where 
the responsibility for that decision takes place; shared decision-making (SDM) at one 
end and informed decision-making at the other. SDM involves at least two parties 
(the client and the professional) and both have to reach consensus (Whelan et al. 
1997). SDM recognises the importance of participant preference but includes a role 
for the health professional who is equipped with the technical knowledge, whereas 
informed decision-making assumes that the participant will make the decision on 
his/her own (Coulter 1997). With SDM, both the process of the decision-making and 
the outcome (intervention choice) are shared, requiring joint access to the evidence 
supporting decisions rather than an abdication of professional responsibility (Coulter 
1997). Some commentators caution that SDM cannot bear the entire burden for 
informing and involving individuals and that population-orientated interventions 
promoting informed decision-making should be explored (Briss et al. 2004).  
 The introduction of participant involvement in decision-making has led to tensions 
between traditionalists and those advocating individual choice. Traditionalists fear 
that the promotion of individual choice may endanger the goal of improving the 
public’s health.  For example, in the UK, following a media-led scare about the 
safety of the combined measles, mumps and rubella vaccination, many parents chose 
not to immunise their children. As a result, the proportion of children immunised fell 
to dangerous levels, and there is now concern about both measles and mumps 
epidemics.  However, individual decision-making need not be incompatible with 
broader public interest or ‘communitarian’ values if the shift in power or decision-
making from professional to patient incorporates autonomy, rights and 
responsibilities (Parker 2001).  
The tension between respecting individual autonomy whilst trying to maximise the 
benefits for the population has been discussed with reference to a population 
cardiovascular screening programme (Marteau et al. 2002). The programme aimed to 
reduce population level morbidity and mortality, and the information provided was 
brief, highlighting the health benefits of participation whilst neglecting the potential 
harms. These ‘harms’ could be the identification of one’s susceptibility to coronary 
heart disease, which would require long term monitoring, adherence to medication 
and/or lifestyle changes. The authors argue that attendance might be reduced if a 
more balanced account of the implications of participation is provided. However, if 
those participating are more motivated to adopt the recommendations, the longer-
term outcomes could be more favourable, and the programme might be more cost-
effective.  
B Problems with delivery 
Little is known about the effects of providing patients with a full account of the risks 
and benefits of the intervention they have been offered. Not only do we not know 
how best to provide this information, we know even less about the effect of 
providing informed decision-making in terms of uptake (Jepson et al. 2000). 
Information may increase knowledge about the intervention, but not acceptability, as 
was found in a study of parental acceptance of HPV screening (See Box 3) 
(Dempsey et al. 2006). It is assumed that the more a person knows about the 
condition and the impact of the intervention, the less the psychological distress will 
be, but this is not supported by evidence.  
The ability of the target audience to absorb the information is important. Data from a 
study assessing the readability of patient information leaflets in general practice 
estimates that five and a half million people in the UK have reading difficulties and 
22% of the working population have low literacy levels (Smith et al. 1998).  This 
issue is even more important in low income countries where literacy levels are lower. 
 The focus of patient information leaflets tends to be on presentation and readability 
rather than content, which can lead to inaccurate and misleading information, based 
on unscientific clinical opinion (Coulter 1998). The basic ground rules of effective 
communication include the exchange of accurate information, exploration of 
anxieties or concerns, opportunities for expressing empathy, awareness of treatment 
options and a negotiation of different views.  
Problems can arise if the information presented are not tailored to individuals’ needs, 
beliefs and values, but rather  have a ‘one size fits all’ approach (Goyder et al. 2000). 
If individuals’ values and competing priorities are not taken into account, both 
participants and health professionals may be faced with conflicting demands.   
Newer technologies such as interactive CD-ROM’s, computer decision tools or the 
Internet may focus attention further onto appearance rather than substance. Few such 
technological decision aids have been evaluated, but it appears that they can improve 
knowledge and realistic expectations, enhance active participation in decision-
making, and improve agreement between choice and values (O'Connor et al. 2003). 
It may be that such advances in communication lead to greater highlighting of the 
uncertainties around medical interventions or outcomes, which in turn may make 
decisions harder to make. A review of the evidence on presenting risk information 
has suggested that when patients receive information which is more understandable, 
they become increasingly cautious in deciding whether to accept treatment, comply 
with interventions or participate in trials (Edwards et al. 2001).   
Even when stringent consent processes are present, and information is provided 
orally and in writing, there may still be a discrepancy between a health professional’s 
account and a lay person’s understanding of the nature of the condition being 
screened for (see Box 2).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B Informed participation – potential tensions 
The tension between individual choice, autonomy and what is considered to be in a 
participant’s best interests is frequently raised. For example, a participant might be 
well informed (presented with the benefits and risks), and then may make a decision 
which the clinician, or health professional feels is not the right one, but this decision 
might be appropriate for the participant (Ashcroft et al. 2001). Decisions are made 
within the context of one’s environment, and this complex interaction must be 
understood and respected when one course of action is chosen over another. 
Sometimes a decision not to undergo further tests might be appropriate, and thus the 
choice not to present for screening should be accepted as a positive outcome if the 
objective of the programme is to encourage informed uptake. 
A systematic review (see Chapter 6) explored the concept of informed uptake, 
examining factors associated with participation, and assessing the effectiveness of 
methods to increase uptake in screening programmes (Jepson et al. 2000).  The 
authors found limited evidence on how providing information affects uptake. Only 
four of the 190 intervention studies reported giving information on the risks and 
Box 2 – Screening for Familial Hyperlipidaemia: an example of 
misunderstanding 
A qualitative study of twenty relatives of individuals with FH (a condition which 
carries a high risk of premature heart disease), found that despite following a 
carefully established protocol, with a high participation rate, there was still much 
misunderstanding and confusion after participants had been screened. 
Understanding of the condition, risk of transmission to self and family and what 
lifestyle modifications were effective differed greatly from the information that the 
nurse thought had been provided.  
It cannot be assumed that just because information is provided, and formal consent 
procedures are undertaken, that people will act in the expected way. Some of the 
participants who tested negative for FH were left with heightened awareness of their 
disease risk and lingering fears about whether they were still at risk of developing 
heart disease. Participation in this screening programme did not allay concerns 
about disease susceptibility. 
This research, using qualitative methods, demonstrated unanticipated effects that 
had not been considered previously. Regrettably, qualitative research is not often 
incorporated into programme evaluations or assessments of social ‘costs’ in cost-
effectiveness analyses.     
(Marks 2004) 
 
 benefits, and only one study evaluated the effect of this knowledge on the decision-
making process. Evidence was inconclusive on how different types of information 
might affect screening knowledge or uptake. This review concluded that when trying 
to increase participation, knowledge should be measured as an outcome in the 
decision-making process, and that future studies should evaluate both informed 
uptake and actual uptake. Giving a balanced account might result in refusal to 
participate, which the health professional may not feel is a sensible choice, but it will 
have to be accepted as a valid outcome.  
  
 
 
  
 
 
 
 
 
Uncertainty still exists about what is the most effective method to convey 
information to individuals, but there is agreement that adequate information should 
be provided.  
 
In evaluating health promotion interventions, ethical aspects including the 
acquisition of consent should be considered;  informed participation as well as actual 
uptake should be evaluated. Individuals make decisions based on their own beliefs 
and values, as well as their own perception of the risks involved. If an individual 
makes an informed decision not to participate, it should be regarded as an 
appropriate decision.  
BBox 3 – Human Papillomavirus (HPV)  vaccination programme in schools 
Thirteen year old girls in the UK are being immunised against HPV, (which causes 
cervical cancer)   through a school-based programme. Because they are aged under 
sixteen, consent is required from a parent or guardian. This might result in discord 
between the young person and parent. The vast majority of research in this area has 
focused on factors relating to parental attitudes and consent, rather than the young 
people’s views.  
Young people aged under sixteen can attend a confidential sexual health clinic and 
access a range of services without parental consent, yet parental consent is required 
for the girl to have the HPV vaccine. A third of parents who were asked their views 
about the child’s right to consent to HPV vaccination within a sexual health setting 
without parental consent, insisted that they still be involved in the decision-making 
process (Brabin et al. 2007). 
 If consent procedures differ from one setting to another, there is the potential for 
friction within the family unit as parental rights are upheld, over those of the 
adolescents.  
 
BKey points 
 Individuals have the right to expect a full explanation of the risks and benefits 
of an intervention before consenting to participate. 
 People have the right to make an informed decision not to participate.  
 If, after assessing the information, a decision not to participate is made, that 
needs to be valued. 
 In evaluating health promotion interventions, informed uptake rather than 
throughput should be measured. 
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